The cumulative dose of gonadotropins used for controlled ovarian stimulation does not influence the odds of embryonic aneuploidy in patients with normal ovarian response

RT @RMAofNY: Proud to collaborate w. @celmatix on the largest study to date analyzing cumulative gonadotropin dosage & incidence of embryon…

RT @RMAofNY: Proud to collaborate w. @celmatix on the largest study to date analyzing cumulative gonadotropin dosage & incidence of embryon…

RT @RMAofNY: Proud to collaborate w. @celmatix on the largest study to date analyzing cumulative gonadotropin dosage & incidence of embryon…

RT @RMAofNY: Proud to collaborate w. @celmatix on the largest study to date analyzing cumulative gonadotropin dosage & incidence of embryon…

RT @RMAofNY: Proud to collaborate w. @celmatix on the largest study to date analyzing cumulative gonadotropin dosage & incidence of embryon…

Proud to collaborate w. @celmatix on the largest study to date analyzing cumulative gonadotropin dosage & incidence of embryonic #aneuploidy https://t.co/7cVU1pNHMw

Check out our latest research article in collaboration w/@RMAofNY in the Journal of Assisted Reproduction & Genetics https://t.co/THHEs2F8pn https://t.co/HHEHWJ7HiF